Series date: 
01/01/2024 - 8:00am EST to 12/31/2024 - 9:00am EST

COURSE DESCRIPTION:
A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered oncology care.

TARGET AUDIENCE:
Dermatology Oncology, Medical Oncologists, Radiation Oncologists, Surgical Oncology, General Surgeons, Pathologists, Radiologists, Pharmacists, Nurses, Social Workers, Radiologic Technologists, Clinical Geneticist, Clinical Genetics Counselors, and all other healthcare personnel involved in the care of cancer patients.
 
EDUCATIONAL OBJECTIVES:

•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.
•    Develop a comprehensive treatment plan for dermatology oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 

FACULTY:

Naiara Braghiroli, MD, PhD, IFAAD
Chief of Skin Cancer and Pigmented Lesions Clinic 
Department of Dermatology
Miami Cancer Institute

Michael C. Raisch, M.D.
Miami Cancer Institute

Gerlem Manso Morin, APRN
Miami Cancer Institute
 

Naiara Braghiroli, MD, PhD, conference director/moderator for this activity has no financial relationships with ineligible companies* to disclose and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

Michael Raisch,M.D., director for this activity has no financial relationships with ineligible companies* to disclose and has indicated that the presentations or discussions will not include off-label or unapproved product usage.


Gerlem Manso Morin, interprofessional coordinator for this activity has no financial relationships with ineligible companies* to disclose.

 DMT coordinators and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

Disclosure Policy and Disclaimer

ACCREDITATION:
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.    

Baptist Health South Florida designates these live activities for a maximum of 1 AMA PRA Category 1 Credit™. each.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

These activities have been approved for 1 credit hour, CE Broker Course #20-989642, by the Florida Boards of Medicine and Osteopathic Medicine.

image

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Series location: 
Miami Cancer Institute
Miami, FL
United States

Sessions

Session Date
Miami Cancer Institute Skin Tumor Board 01/04/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 01/11/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 01/18/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 01/25/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 02/01/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 02/08/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 02/15/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 02/22/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 02/29/2024 - 8:00am to 9:00am EST
Miami Cancer Institute Skin Tumor Board 03/07/2024 - 8:00am to 9:00am EST

Pages